secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNS Pharmaceuticals, Inc. (CNSP)
CIK:        0001729427
Form:       8-K
Filed at:   2024-02-27T23:59:59+00:00
Accession:  0001683168-24-001219
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CNS Pharma receives Nasdaq bid-price deficiency notice; board committee changes
-------------------------------------------------------------------------------

- On Feb 27, 2024, Nasdaq notified CNS Pharma common stock bid price closed below $1.00 for 30 consecutive business days, violating Rule 5550(a)(2).
- Company has 180 days until Aug 26, 2024 to regain compliance by closing at $1.00+ for at least 10 consecutive business days.
- This follows a prior delisting notice for failing to meet $2.5M stockholders' equity; hearing requested and stay granted.
- Board appointed committee chairs: Audit (Keyes), Compensation (Gumulka), Nominating/Governance (Cockroft) effective Feb 21, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824001219/0001683168-24-001219-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729427/000168316824001219/cns_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-001219

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer